STRESS PROTEIN 60 DURING MYOCARDIAL ISCHEMIA
心肌缺血期间的应激蛋白 60
基本信息
- 批准号:2211221
- 负责人:
- 金额:$ 10.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-08-01 至 1997-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Coronary artery disease can lead to chronic heart failure, need for
revascularization (by-pass surgery), or life-threatening cardiac
arrhythmias. It is the cause of one and a half million acute myocardial
infarctions per year in the USA, more than half of them lethal. Its cost
is the highest of all Current medical diseases in the nation. Coronary
artery disease affects the blood supply of the heart muscle (myocardium)
and, therefore, decreases oxygen delivery to myocardial cells. The
mitochondria of cardiac myocytes is one of the major targets for ischemia-
induced damage. Limitations of oxygen delivery reduces mitochondrial
oxidative phosphorylation and contributes to the reduction of
intracellular ATP levels. Some investigators have indicated that the
inability of the mitochondria to self-repair following restoration of
blood flow may be one of the crucial events leading to the ultimate death
of myocardial cells. Although it is not clear if sarcolemmal or
mitochondrial damage is the main event in the irreversible damage of the
myocardial cell, the role of mitochondrial changes in decreased myocardial
functions are not questioned. Recent studies have shown that heat shock
protein (HSP) 60, which is a member of the stress protein family and are
thought to have a protective role during oxidative stress, is required for
the assembly of multimeric enzyme complexes within the mitochondria. We
have recently found that during acute occlusion of the descending coronary
artery for 30 minutes in the rat heart, which leads to ischemia in the
left ventricle, there is a marked and specific increase in HSP6O mRNA
level. This finding leads us to believe that HSP6O as other related HSPs
may have a protective role and is probably involved in the repair of the
mitochondrial enzymatic complexes vital for the normal function of the
mitochondria. It is our objective to investigate this ischemia-induced
change in HSP6O expression and determine if HSP60 mediates protection
processes in the mitochondria that contribute to recovery from ischemic
injury in the myocardial cell.
冠状动脉疾病可导致慢性心力衰竭,需要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RUBEN MESTRIL其他文献
RUBEN MESTRIL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RUBEN MESTRIL', 18)}}的其他基金
MITOCHONDRIAL STRESS PROTEINS AND CARDIOPROTECTION
线粒体应激蛋白和心脏保护
- 批准号:
6390093 - 财政年份:2000
- 资助金额:
$ 10.61万 - 项目类别:
MITOCHONDRIAL STRESS PROTEINS AND CARDIOPROTECTION
线粒体应激蛋白和心脏保护
- 批准号:
6619566 - 财政年份:2000
- 资助金额:
$ 10.61万 - 项目类别:
MITOCHONDRIAL STRESS PROTEINS AND CARDIOPROTECTION
线粒体应激蛋白和心脏保护
- 批准号:
6192642 - 财政年份:2000
- 资助金额:
$ 10.61万 - 项目类别:
MITOCHONDRIAL STRESS PROTEINS AND CARDIOPROTECTION
线粒体应激蛋白和心脏保护
- 批准号:
6527373 - 财政年份:2000
- 资助金额:
$ 10.61万 - 项目类别:
相似海外基金
Development of a method for preserving transplanted lung function using Gapmer-type antisense nucleic acid
开发利用Gapmer型反义核酸保存移植肺功能的方法
- 批准号:
22K09003 - 财政年份:2022
- 资助金额:
$ 10.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Myostatin antisense nucleic acid therapy for rhabdomyosarcoma
肌肉生长抑制素反义核酸治疗横纹肌肉瘤
- 批准号:
21K07762 - 财政年份:2021
- 资助金额:
$ 10.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Suppression of PHOX2B (+7Ala mutant) expression by antisense nucleic acid
反义核酸抑制 PHOX2B(7Ala 突变体)表达
- 批准号:
20K16927 - 财政年份:2020
- 资助金额:
$ 10.61万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Pathogenesis and Antisense nucleic acid, glycosylation supplementation, and AAV therapy development forFukuyama muscular dystrophy and related diseases
福山性肌营养不良症及相关疾病的发病机制和反义核酸、糖基化补充以及 AAV 疗法的开发
- 批准号:
20H00526 - 财政年份:2020
- 资助金额:
$ 10.61万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Synthesis of antisense nucleic acid incorporating cyclic sulfonamide backbone
掺入环状磺酰胺主链的反义核酸的合成
- 批准号:
20K21245 - 财政年份:2020
- 资助金额:
$ 10.61万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Antisense nucleic acid splice correction therapy for Duchenne muscular dystrophy and related disorders
杜氏肌营养不良症及相关疾病的反义核酸剪接校正疗法
- 批准号:
G0900887/1 - 财政年份:2011
- 资助金额:
$ 10.61万 - 项目类别:
Research Grant
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID "2'-PHOSPHORYLATED RNAS" -DIRECTED TOWARD ITS BASIC STRUCTURAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
反义核酸新材料“2-磷酸化RNAS”的化学合成-针对其基础结构研究和HIV病毒表达调控-
- 批准号:
05558090 - 财政年份:1993
- 资助金额:
$ 10.61万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID"2"PHOSTHORYLATEDRNAS" DIRETED TOWARD IIS BASIC STRUCTRAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
针对 IIS 基础结构研究和 HIV 病毒表达调控的反义核酸新材料“2”磷酸化 RNA 的化学合成-
- 批准号:
04453031 - 财政年份:1992
- 资助金额:
$ 10.61万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)